Serum concentrations of immune parameters during acute cardiogenic pulmonary edema.
OBJECTIVE
To evaluate the effect of acute cardiogenic pulmonary edema on the concentrations of immune parameters in serum.


METHODS
Prospective, controlled study.


METHODS
Medical ICU.


METHODS
Twenty-four consecutive patients with acute pulmonary edema who had significant clinical improvement within 30 mins and did not show any evidence of either tissue damage or infection. For comparison, 25 healthy, age-matched controls and 25 patients with mild chronic heart failure were also studied.


METHODS
Treatment with oxygen, nitrates, and loop diuretics.


METHODS
Lymphokines, acute-phase reactants, and cortisol concentrations were measured in serial serum and plasma samples.


RESULTS
Serum concentrations of soluble CD-8 antigen (soluble CD-8) decreased from 928 +/- 124 (SEM) U/mL on admission to 712 +/- 112 and 579 +/- 67 U/mL after 2 and 6 hrs, respectively (p less than .05, p less than .01), and returned to baseline values within 48 hrs (853 +/- 109 U/mL). Concentrations of soluble interleukin-2 receptor increased from 721 +/- 71 to 1078 +/- 112 and 1226 +/- 128 U/mL 12 and 36 hrs, respectively, after admission (p less than .05, p less than .01). Plasma cortisol concentrations were markedly increased on admission (56.9 +/- 4.7 vs. 13.1 +/- 1.3 micrograms/dL after recovery, p less than .001). Increased cortisol concentrations coincided with the nadir of soluble CD-8. Tumor necrosis factor-alpha remained within normal limits in all patients. Neither acute-phase reactants nor angiotensin converting enzyme activity showed significant changes during the observation period.


CONCLUSIONS
The present results indicate significant alterations in the serum concentrations of immune parameters as an effect of an uncomplicated acute cardiogenic pulmonary edema.
Kurz
R W
RW
First Medical Department, Kaiser Franz Josef Spital, Vienna, Austria.
Stockenhuber
F
F
Gremmel
F
F
Graninger
W
W
D000208:Acute Disease; D000209:Acute-Phase Proteins / Q000032:analysis; D000368:Aged; D000369:Aged, 80 and over; D016827:CD8 Antigens / Q000097:blood; D005260:Female; D006331:Heart Diseases / Q000150:complications / Q000276:immunology*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000097:blood; D011654:Pulmonary Edema / Q000209:etiology / Q000276:immunology*; D015375:Receptors, Interleukin-2 / Q000032:analysis; D012995:Solubility; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D000209:Acute-Phase Proteins; D016827:CD8 Antigens; D015375:Receptors, Interleukin-2; D014409:Tumor Necrosis Factor-alpha; D007703:Peptidyl-Dipeptidase A; D006854:Hydrocortisone